SEC Filing Summary

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving 8.8988 Deferred Stock Units on October 2, 2026. These units, representing the right to receive one share of Company common stock or its cash equivalent, were acquired at a price of $22.14 per unit. Following this transaction, Mr. VanHimbergen holds 167.5523 units. The deferred stock units are set to settle in cash or shares of Company common stock subsequent to his termination of employment or during a specified future year, as outlined in the Executive Deferral and Stock Match Plan. This filing is categorized as an OFFICER_DIRECTOR_CHANGE due to the nature of the transaction involving a company executive.